Portola Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch PTLA and buy or sell other stocks, ETFs, and their options commission-free!

About PTLA

Portola Pharmaceuticals LLC engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines.

CEO

J. Scott Garland, MBA

CEOJ. Scott Garland, MBA

Employees

—

Employees—

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2003

Founded2003

Employees

—

Employees—

PTLA Key Statistics

Market cap

1.42B

Market cap1.42B

Price-Earnings ratio

-4.78

Price-Earnings ratio-4.78

Dividend yield

—

Dividend yield—

Average volume

2.32M

Average volume2.32M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$31.73

52 Week high$31.73

52 Week low

$5.31

52 Week low$5.31

People also own

Based on the portfolios of people who own PTLA. This list is generated using Robinhood data, and it’s not a recommendation.